These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 21803956
1. Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma. Kubica AW, Rose PS, Weaver AL, Brewer JD. Mayo Clin Proc; 2011 Aug; 86(8):738-43. PubMed ID: 21803956 [Abstract] [Full Text] [Related]
2. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia. Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL, Otley CC. Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131 [Abstract] [Full Text] [Related]
3. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma. Famenini S, Martires KJ, Zhou H, Xavier MF, Wu JJ. J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434 [Abstract] [Full Text] [Related]
4. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota. Brewer JD, Shanafelt TD, Khezri F, Sosa Seda IM, Zubair AS, Baum CL, Arpey CJ, Cerhan JR, Call TG, Roenigk RK, Smith CY, Weaver AL, Otley CC. J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909 [Abstract] [Full Text] [Related]
6. Clinicopathological characteristics and survival of malignant fibrous histiocytoma of the bone: A population-based study using the SEER database. Liu B, Wei H, Ren YJ, Zou D, Zhang K, Ma Q, Xiao X. PLoS One; 2020 Feb; 15(6):e0232466. PubMed ID: 32492019 [Abstract] [Full Text] [Related]
7. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia. Cerhan JR, Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD, Sellers TA, Folsom AR. Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728 [Abstract] [Full Text] [Related]
8. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype. Abuamsha H, Kadri AN, Hernandez AV. Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804 [Abstract] [Full Text] [Related]
11. Pigmentary traits, sun exposure, and risk of non-Hodgkin's lymphoma/chronic lymphocytic leukemia: A study within the French E3N prospective cohort. Garcin LM, Gelot A, Gomez RR, Gusto G, Boutron-Ruault MC, Kvaskoff M, Severi G, Besson C. Cancer Med; 2021 Jan; 10(1):297-304. PubMed ID: 33219744 [Abstract] [Full Text] [Related]
12. Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study. McBride A, Daniel S, Driessen MT, Szende A, Choudhry A, Tian M, Ariely R, Thompson S. Leuk Res; 2021 Dec; 111():106671. PubMed ID: 34530254 [Abstract] [Full Text] [Related]
14. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study. Palanca-Wessels MC, Czuczman M, Salles G, Assouline S, Sehn LH, Flinn I, Patel MR, Sangha R, Hagenbeek A, Advani R, Tilly H, Casasnovas O, Press OW, Yalamanchili S, Kahn R, Dere RC, Lu D, Jones S, Jones C, Chu YW, Morschhauser F. Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619 [Abstract] [Full Text] [Related]
15. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma. Chang TW, Weaver AL, Shanafelt TD, Habermann TM, Wriston CC, Cerhan JR, Call TG, Brewer JD. Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851 [Abstract] [Full Text] [Related]
16. Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study. Tietsche de Moraes Hungria V, Chiattone C, Pavlovsky M, Abenoza LM, Agreda GP, Armenta J, Arrais C, Avendaño Flores O, Barroso F, Basquiera AL, Cao C, Cugliari MS, Enrico A, Foggliatto LM, Galvez KM, Gomez D, Gomez A, de Iracema D, Farias D, Lopez L, Mantilla WA, Martínez D, Mela MJ, Miguel CE, Ovilla R, Palmer L, Pavlovsky C, Ramos C, Remaggi G, Santucci R, Schusterschitz S, Sossa CL, Tuna-Aguilar E, Vela J, Santos T, de la Mora O, Machnicki G, Fernandez M, Barreyro P. J Glob Oncol; 2019 Nov; 5():1-19. PubMed ID: 31774711 [Abstract] [Full Text] [Related]
17. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure. Russo AL, Chen YH, Martin NE, Vinjamoori A, Luthy SK, Freedman A, Michaelson EM, Silver B, Mauch PM, Ng AK. Int J Radiat Oncol Biol Phys; 2013 May 01; 86(1):121-7. PubMed ID: 23414765 [Abstract] [Full Text] [Related]
19. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis? Pamuk GE, Uyanik MS, Pamuk ON, Maden M, Tapan U. Hematology; 2015 Jun 01; 20(5):267-71. PubMed ID: 25271869 [Abstract] [Full Text] [Related]
20. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM. J Clin Oncol; 2015 Oct 01; 33(28):3096-104. PubMed ID: 26240221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]